Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2026-03-09 @ 2:44 AM
Study NCT ID:
NCT01756950
Status:
COMPLETED
Last Update Posted:
2013-12-19
First Post:
2012-12-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses
Sponsor:
Crucell Holland BV
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FLU-M8-A001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |